Cargando…
Clinicopathologic and (11)C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
Thal amyloid phase, which describes the pattern of progressive amyloid-β plaque deposition in Alzheimer’s disease, was incorporated into the latest National Institute of Ageing – Alzheimer’s Association neuropathologic assessment guidelines. Amyloid biomarkers (positron emission tomography and cereb...
Autores principales: | Murray, Melissa E., Lowe, Val J., Graff-Radford, Neill R., Liesinger, Amanda M., Cannon, Ashley, Przybelski, Scott A., Rawal, Bhupendra, Parisi, Joseph E., Petersen, Ronald C., Kantarci, Kejal, Ross, Owen A., Duara, Ranjan, Knopman, David S., Jack, Clifford R., Dickson, Dennis W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407190/ https://www.ncbi.nlm.nih.gov/pubmed/25805643 http://dx.doi.org/10.1093/brain/awv050 |
Ejemplares similares
-
β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020) -
An autoradiographic evaluation of AV-1451 Tau PET in dementia
por: Lowe, Val J., et al.
Publicado: (2016) -
(18)F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
por: Nedelska, Zuzana, et al.
Publicado: (2019) -
White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023) -
β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)